The closing price of Nevro Corp (NYSE: NVRO) was $14.34 for the day, down -2.18% from the previous closing price of $14.66. In other words, the price has decreased by -$0.32 from its previous closing price. On the day, 535897 shares were traded.
Ratios:
Our analysis of NVRO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.94 and its Current Ratio is at 6.37. In the meantime, Its Debt-to-Equity ratio is 0.76 whereas as Long-Term Debt/Eq ratio is at 0.74.
On January 12, 2024, RBC Capital Mkts Downgraded its rating to Sector Perform which previously was Outperform and also lowered its target price recommendation from $23 to $20.
Canaccord Genuity Downgraded its Buy to Hold on December 21, 2023, while the target price for the stock was maintained at $23.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 07 ’23 when McCormick Shawn bought 7,500 shares for $22.88 per share. The transaction valued at 171,633 led to the insider holds 26,866 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVRO now has a Market Capitalization of 521.95M and an Enterprise Value of 415.33M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.23 while its Price-to-Book (P/B) ratio in mrq is 1.78. Its current Enterprise Value per Revenue stands at 0.98 whereas that against EBITDA is -5.30.
Stock Price History:
Over the past 52 weeks, NVRO has reached a high of $39.67, while it has fallen to a 52-week low of $13.36. The 50-Day Moving Average of the stock is 17.10, while the 200-Day Moving Average is calculated to be 19.66.
Shares Statistics:
NVRO traded an average of 515.30K shares per day over the past three months and 501.14k shares per day over the past ten days. A total of 36.36M shares are outstanding, with a floating share count of 35.08M. Insiders hold about 3.63% of the company’s shares, while institutions hold 105.42% stake in the company.
Earnings Estimates
The firm’s stock currently is rated by 15 analysts. On average, analysts expect EPS of -$1.05 for the current quarter, with a high estimate of -$0.77 and a low estimate of -$1.26, while EPS last year was -$0.98. The consensus estimate for the next quarter is -$0.65, with high estimates of -$0.52 and low estimates of -$0.81.
Analysts are recommending an EPS of between -$2.19 and -$3.13 for the fiscal current year, implying an average EPS of -$2.66. EPS for the following year is -$2.25, with 16 analysts recommending between -$1.9 and -$2.79.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 16 analysts. It ranges from a high estimate of $98.46M to a low estimate of $97.18M. As of the current estimate, Nevro Corp’s year-ago sales were $95.18M, an estimated increase of 2.80% from the year-ago figure. For the next quarter, 16 analysts are estimating revenue of $111.22M, an increase of 2.20% less than the figure of $2.80% in the same quarter last year. There is a high estimate of $114.14M for the next quarter, whereas the lowest estimate is $107M.
A total of 17 analysts have provided revenue estimates for NVRO’s current fiscal year. The highest revenue estimate was $449.65M, while the lowest revenue estimate was $434.6M, resulting in an average revenue estimate of $440.82M. In the same quarter a year ago, actual revenue was $425.17M, up 3.70% from the average estimate. Based on 17 analysts’ estimates, the company’s revenue will be $467.1M in the next fiscal year. The high estimate is $482.67M and the low estimate is $456.3M. The average revenue growth estimate for next year is up 6.00% from the average revenue estimate for this year.
